期刊文献+

负载焦亡抑制剂的活性氧响应性自组装纳米胶束对糖尿病大鼠全层皮肤缺损的影响 被引量:1

Influence of reactive oxygen species responsive self-assembled nanomicelle loaded with pyroptosis inhibitor on full-thickness skin defects in diabetic rats
原文传递
导出
摘要 目的探究负载焦亡抑制剂的活性氧响应性自组装纳米胶束对糖尿病大鼠全层皮肤缺损的影响。方法采用实验研究方法。用纳米胶束聚乙二醇-嵌段-聚丙烯硫醚(PEG-b-PPS)包封核苷酸结合寡聚化结构域(NOD)1/2抑制剂(NOD-IN-1),将所得产物称为PEPS@NOD-IN-1。利用透射电子显微镜和粒度分析仪分别观测PEG-b-PPS与PEPS@NOD-IN-1的形貌和水合粒径,用酶标仪测量并计算PEPS@NOD-IN-1对NOD-IN-1的包封率和载药率以及PEPS@NOD-IN-1在单纯磷酸盐缓冲液(PBS)和含过氧化氢的PBS中40 h内对NOD-IN-1的累积释放率,样本数均为3。取24只6~7周龄雄性SD大鼠,通过注射链脲佐菌素的方法诱导1型糖尿病,在每只大鼠背部制作6个全层皮肤缺损创面,按随机数字表法将致伤大鼠分为进行相应处理的PBS组、NOD-IN-1组、PEG-b-PPS组、PEPS@NOD-IN-1组,每组6只。伤后3、7、12 d观察创面愈合情况并计算创面愈合率;伤后3 d,采用免疫荧光法检测创面组织中活性氧水平;伤后7 d,利用苏木精-伊红染色评估创面肉芽组织厚度,采用实时荧光定量反转录PCR法检测创面组织中NOD1、NOD2的mRNA表达,采用蛋白质印迹法检测创面组织中NOD1、NOD2、GSDMD-N端的蛋白表达。前述指标均各取各组不同鼠的共6个创面检测。另取PBS组和PEPS@NOD-IN-1组大鼠伤后7 d创面组织(各3个样本),利用高通量测序技术平台进行转录组测序,筛选出PEPS@NOD-IN-1组相较于PBS组显著下调的差异表达基因(DEG),进行京都基因与基因组百科全书(KEGG)富集分析;制作焦亡相关通路NOD样受体通路DEG热图;通过STRING数据库对热图中的DEG进行蛋白质-蛋白质相互作用(PPI)分析,筛选PEPS@NOD-IN-1调控NOD样受体通路的关键基因。对数据行重复测量方差分析、单因素方差分析、Tukey检验。结果PEG-b-PPS与PEPS@NOD-IN-1均为大小较为均一的球形结构,水合粒径分别为(134.2±3.3)、(143.1±2.3)nm。PEPS@NOD-IN-1对NOD-IN-1的包封率为(60±5)%、载药率为(15±3)%。PEPS@NOD-IN-1在单纯PBS中对NOD-IN-1的释放较缓慢,40 h累积释放率仅为(12.4±2.3)%;PEPS@NOD-IN-1在含过氧化氢的PBS中10 h内对NOD-IN-1的释放十分迅速,10 h累积释放率已达(90.1±3.6)%。伤后3、7 d,4组大鼠创面均逐渐愈合,PEPS@NOD-IN-1组愈合情况优于其余3组;伤后12 d,PBS组创面结痂面积较大,NOD-IN-1组、PEG-b-PPS组创面上皮化明显,PEPS@NOD-IN-1组创面接近完全上皮化。与PBS组、NOD-IN-1组及PEG-b-PPS组比较,PEPS@NOD-IN-1组大鼠伤后7、12 d创面愈合率均显著增高(P<0.05),伤后3 d创面组织中活性氧水平显著下降(P<0.05),伤后7 d创面肉芽组织厚度显著增厚(P<0.05),伤后7 d创面组织中NOD1、NOD2的mRNA表达以及NOD1、NOD2、GSDMD-N端的蛋白表达均显著下降(P<0.05)。KEGG通路分析显示,PEPS@NOD-IN-1组相较于PBS组显著下调的DEG在NOD样受体、缺氧诱导因子、丝裂原活化蛋白激酶和肿瘤坏死因子(TNF)通路方面显著富集。在NOD样受体通路的DEG热图中,可见调控细胞焦亡的基因主要涉及NOD1、NOD2、NOD样受体热蛋白结构域相关蛋白3、Jun、信号转导及转录激活因子1(STAT1)、TNF-α诱导蛋白3。PPI结果显示,NOD1、NOD2、STAT1为PEPS@NOD-IN-1调控NOD样受体通路的关键基因。结论PEPS@NOD-IN-1能下调创面局部活性氧水平及细胞焦亡关键调节因子NOD1、NOD2、GSDMD-N端的表达,进而促进糖尿病大鼠全层皮肤缺损创面修复;PEPS@NOD-IN-1还可显著下调创面的焦亡、炎症及缺氧相关通路,通过下调关键基因NOD1、NOD2、STAT1调控NOD样受体通路。 Objective To investigate the influence of reactive oxygen species(ROS)responsive self-assembled nanomicelle loaded with pyroptosis inhibitor on full-thickness skin defects in diabetic rats.Methods Experimental research methods were employed.A nucleotide-binding oligomerization domain(NOD)1/2 inhibitor(NOD-IN-1)was encapsulated with nanomicelle polyethylene glycol-block-polypropylene sulfide(PEG-b-PPS),and the resulting product was called PEPS@NOD-IN-1.The morphology and hydration particle size of PEG-b-PPS and PEPS@NOD-IN-1 were observed by transmission electron microscope and particle size analyzer,respectively,and the encapsulation rate and drug loading rate of PEPS@NOD-IN-1 to NOD-IN-1 and the cumulative release rate of NOD-IN-1 by PEPS@NOD-IN-1 in phosphate buffer solution(PBS)alone and hydrogen peroxide-containing PBS within 40 h were measured and calculated by microplate reader,and the sample number was 3.Twenty-four male Sprague-Dawley rats aged 6−7 weeks were injected with streptozotocin to induce type 1 diabetes mellitus.Six full-thickness skin defect wounds were made on the back of each rat.The injured rats were divided into PBS group,NOD-IN-1 group,PEG-b-PPS group,and PEPS@NOD-IN-1 group with corresponding treatment according to the random number table,with 6 rats in each group.The wound healing was observed on post injury day(PID)3,7,and 12,and the wound healing rate was calculated.The ROS levels in wound tissue were detected by immunofluorescence method on PID 3.On PID 7,the granulation tissue thickness in wound was assessed by hematoxylin-eosin staining,the mRNA expressions of NOD1 and NOD2 were detected by real-time fluorescence quantitative reverse transcription polymerase chain reaction,and the protein expressions of NOD1,NOD2,and GSDMD-N terminals were detected by Western blotting.Six wounds from different rats in each group were taken for detection of the above indicators.Wound tissue(3 samples per group)was taken from rats in PBS group and PEPS@NOD-IN-1 group on PID 7,and transcriptome sequencing was performed using high-throughput sequencing technology platform.Differentially expressed genes(DEGs)significantly down-regulated in PEPS@NOD-IN-1 group as compared with PBS group were screened,and the enrichment analysis of Kyoto Encyclopedia of Genes and Genomes(KEGG)was performed.The DEG heatmap of the NOD-like receptor pathway,a pyroptosis-related pathway,was made.Protein-protein interaction(PPI)analysis of DEGs in heatmap was performed through the STRING database to screen key genes of PEPS@NOD-IN-1 regulating the NOD-like receptor pathway.Data were statistically analyzed with analysis of variance for repeated measurement,one-way analysis of variance,and Tukey test.Results PEG-b-PPS and PEPS@NOD-IN-1 were in spherical structures of uniform size,with hydration particle sizes of(134.2±3.3)and(143.1±2.3)nm,respectively.The encapsulation rate of PEPS@NOD-IN-1 to NOD-IN-1 was(60±5)%,and the drug loading rate was(15±3)%.The release of NOD-IN-1 from PEPS@NOD-IN-1 in PBS alone was slow,and the cumulative release rate at 40 h was only(12.4±2.3)%.The release of NOD-IN-1 from PEPS@NOD-IN-1 in hydrogen peroxide-containing PBS within 10 h was very rapid,and the cumulative release rate at 10 h reached(90.1±3.6)%.On PID 3 and 7,the wounds of rats in the four groups were gradually healed,and the healing in PEPS@NOD-IN-1 group was better than that in the other three groups.On PID 12,the wound scab area in PBS group was large,the wound epithelialization in NOD-IN-1 group and PEG-b-PPS group was obvious,and the wound in PEPS@NOD-IN-1 group was close to complete epithelialization.Compared with those in PBS group,NOD-IN-1 group,and PEG-b-PPS group,the wound healing rates on PID 7 and 12 in PEPS@NOD-IN-1 group were significantly increased(P<0.05),the level of ROS in wound tissue on PID 3 was significantly decreased(P<0.05),the thickness of granulation tissue in wound on PID 7 was significantly thickened(P<0.05),and the mRNA expressions of NOD1 and NOD2 and the protein expressions of NOD1,NOD2,and GSDMD-N terminals in wound tissue on PID 7 were significantly decreased(P<0.05).KEGG pathway analysis showed that DEGs significantly down-regulated in PEPS@NOD-IN-1 group as compared with PBS group were significantly enriched in NOD-like receptors,hypoxia-inducible factors,mitogen-activated protein kinases,and tumor necrosis factor(TNF)pathways.In the DEG heatmap of NOD-like receptor pathway,the genes regulating pyroptosis mainly involved NOD1,NOD2,NOD-like receptor thermoprotein domain-related protein 3,Jun,signal transduction and transcriptional activator 1(STAT1),TNF-α-induced protein 3.The PPI results showed that NOD1,NOD2,and STAT1 were the key genes of PEPS@NOD-IN-1 regulating the NOD-like receptor pathway.Conclusions PEPS@NOD-IN-1 can down-regulate the level of local ROS in wounds and the expression of NOD1,NOD2,and GSDMD-N terminals,the key regulators of pyroptosis,thereby promoting the repair of full-thickness skin defect wounds in diabetic rats.PEPS@NOD-IN-1 can also significantly down-regulate the pyroptosis,inflammation,and hypoxia-related pathways of wounds,and regulate NOD-like receptor pathways by down-regulating key genes NOD1,NOD2,and STAT1.
作者 欧泽林 王珏 时荣 邓君 刘毅 罗高兴 Ou Zelin;Wang Jue;Shi Rong;Deng Jun;Liu Yi;Luo Gaoxing(Department of Nephrology,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,China;State Key Laboratory of Trauma,Burns and Combined Injury,Institute of Burn Research,the First Affiliated Hospital of Army Medical University(the Third Military Medical University),Chongqing Key Laboratory for Disease Proteomics,Chongqing 400038,China)
出处 《中华烧伤与创面修复杂志》 CAS CSCD 北大核心 2023年第1期35-44,共10页 Chinese Journal of Burns And Wounds
基金 国家自然科学基金国际(地区)合作与交流项目(81920108022)。
关键词 糖尿病 1型 材料试验 活性氧 细胞焦亡 创面修复 转录组测序 Diabetes mellitus,type 1 Materials testing Reactive oxygen species Pyroptosis Wound repair Transcriptome sequencing
  • 相关文献

参考文献3

二级参考文献40

  • 1余波,罗师平,宋丽萍,冷希岗,赵明辉,牛惠生.氨基酸序列突变对TFPI生物半衰期和生物活性的影响[J].生物化学与生物物理进展,2007,34(4):382-388. 被引量:3
  • 2Werner M E, Karve S, Sukumar R, et al. Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. Biomaterials, 2011, 32: 8548-8554.
  • 3Barreto J A, Malley W O, Kubeil M, et al. Nanomaterials: Applications in cancer imaging and therapy. Adv Healthcare Mater, 2011, 23: 18-40.
  • 4Maeda H, Bharate G Y, Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eng Polymers Control Drug Delivery Target, 2009, 71: 409-419.
  • 5Low P S, Kularatne S A. Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol, 2009, 13: 256-262.
  • 6Low P S, Henne W A, Doorneweerd D D. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and in?ammatory diseases. Acc Chem Res, 2008, 41: 120-129.
  • 7Xia W, Low P S. Folate-targeted therapies for cancer. J Med Chem, 2010, 53: 6811-6824.
  • 8Finkelstein J D. Methionine metabolism in mammals. J Nutr Biochem, 1990, 1: 228-237.
  • 9Lin J, Raoof D A, Thomas D G, et al. L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma. Neoplasia, 2004, 6: 74-84.
  • 10Halpern B C, Clark B R, Hardy D N, et al. The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc Natl Acad Sci USA, 1974, 71: 1133-1136.

共引文献3

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部